First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy
Go back to First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 19.17 -0.56 (2.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.73 | 52 Week High | $63.73 | |||
| Open | $19.42 | 52 Week Low | $8.00 | |||
| Day High | $19.95 | P/E | N/A | |||
| Day Low | $18.59 | EPS | $-5.69 | |||
| Volume | 1,391,295 | |||||
